INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Operating Profit History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹19 Cr | ₹11 Cr | ₹9.39 Cr | ₹6.93 Cr | ₹5.51 Cr |
What is the latest Operating Profit of INDO US BIOTECH ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹9.39 Cr |
| Mar2022 | ₹6.93 Cr |
| Mar2021 | ₹5.51 Cr |
How is Operating Profit of INDO US BIOTECH Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | 75.26 | |
| Mar2024 | ₹11 Cr | 15.03 | |
| Mar2023 | ₹9.39 Cr | 35.52 | |
| Mar2022 | ₹6.93 Cr | 25.70 | |
| Mar2021 | ₹5.51 Cr | - | |
Compare Operating Profit of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹266.1 Cr | 9% | -2.9% | -55.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,863.8 Cr | -3.9% | -9.4% | -25.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,000.7 Cr | -4.7% | -8.3% | 21.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,888.6 Cr | -0.7% | -7.8% | -20.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,156.9 Cr | -2.8% | -12.2% | -21.8% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹513.8 Cr | 5.1% | 3.7% | 33.2% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 9% |
-2.9% |
-55.9% |
| SENSEX | 0.5% |
1.7% |
11% |
You may also like the below Video Courses